This is an International biomedical and genetic resource for the study of type 2 diabetes and related conditions and is available to researchers worldwide. International researchers will collaborate through a researcher based in the UK. The Access Policy describes all the information and processes required to make a request to access this resource. All access will be made through members of the Access Group, following the procedures laid out in the Access Policy
The patient consent at time of recruitment allows the data collected to be linked anonymously to datasets derived from consenting patients medical records. These datasets include laboratory data, hospital admissions and outpatient appointments and SCI-DC-an electronic record used by health care professionals throughout Scotland for the care of patients with diabetes.
Baseline data summary statistics are available as PDF document.
See Access Policy below for details of the management of GoDARTS.
To apply for access to data, samples from the resource please complete the form below
DNA samples are analysed for their sequencing. Serum samples will be analysed for chemical and biochemical components of either established or new biomarkers. RNA samples will be analysed for the sequence and relative content of individual RNA molecules (Mrna, microRNA, ncRNA etc